Search

everythinglearnresearchcommunity

for

Search:↓

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Understanding sex and gender differences can improve personalized dermatology care.

Athletic trainers should understand and support the medical needs of transgender and gender-diverse patients.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Gender-affirming care for youth remained essential during the COVID-19 pandemic, with telemedicine playing a key role.

Transgender individuals face unique skin issues, often due to hormone therapy, requiring specialized and stigma-free dermatologic care.

Transgender and gender-diverse teens need specialized skin and mental health care.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

The statement offers guidance for hormone therapy and surgery to help gender-incongruent adults affirm a male identity.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Adults with gender dysphoria on hormone treatment often have skin problems like acne, which are common but not always recognized.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

Topical 3% minoxidil effectively and safely enhances facial hair in transgender men.

Dermatologists should address discrimination and consider ethnic and gender differences in treatments.

Provide individualized, supportive care for transgender and non-binary adolescents to improve their well-being.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Transgender men need personalized cancer care and continued testosterone therapy for well-being.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.

Bicalutamide may help treat female pattern hair loss.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Both steroids, especially cyproterone acetate, harm quail's vital organs.

Accurate gender and sex assessment in dermatology is essential for respectful and precise patient care.

Pediatric dermatologists need to understand the unique skin health needs of LGBTQIA youth to provide better care.

Healthcare providers need better education and policies to serve transgender individuals effectively.